Salud financiera de hoja de balance de Innolux

Salud financiera controles de criterios 4/6

Innolux tiene un patrimonio de los accionistas total de NT$228.9B y una deuda total de NT$43.4B, lo que sitúa su ratio deuda-patrimonio en 19%. Sus activos y pasivos totales son NT$357.5B y NT$128.6B respectivamente.

Información clave

19.0%

Ratio deuda-patrimonio

NT$43.44b

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	NT$62.63b
Patrimonio	NT$228.89b
Total pasivo	NT$128.65b
Activos totales	NT$357.53b

Actualizaciones recientes sobre salud financiera

Recent updates

Health Check: How Prudently Does Innolux (TWSE:3481) Use Debt?

Apr 04

Analysts Have Lowered Expectations For Innolux Corporation (TWSE:3481) After Its Latest Results

Feb 27

Estimating The Intrinsic Value Of Innolux Corporation (TPE:3481)

Apr 12

Here's Why Innolux (TPE:3481) Can Manage Its Debt Responsibly

Mar 25

Is Now The Time To Look At Buying Innolux Corporation (TPE:3481)?

Mar 04

Is Innolux (TPE:3481) Headed For Trouble?

Feb 11

Did You Miss Innolux's (TPE:3481) 42% Share Price Gain?

Jan 21

Is There An Opportunity With Innolux Corporation's (TPE:3481) 25% Undervaluation?

Dec 26

Is Innolux (TPE:3481) A Risky Investment?

Nov 30

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$133.7B) de 3481 superan a sus pasivos a corto plazo (NT$87.6B).

Pasivo a largo plazo: Los activos a corto plazo de 3481 (NT$133.7B) superan a sus pasivos a largo plazo (NT$41.1B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3481 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 3481 ha crecido de 18.1% a 19% en los últimos 5 años.

Cobertura de la deuda: La deuda de 3481 está bien cubierta por el flujo de caja operativo (22%).

Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 3481 sobre su deuda están bien cubiertos por el EBIT.

Hoja de balance

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de Innolux

Salud financiera controles de criterios 4/6

Información clave

Actualizaciones recientes sobre salud financiera

Health Check: How Prudently Does Innolux (TWSE:3481) Use Debt?

Here's Why Innolux (TPE:3481) Can Manage Its Debt Responsibly

Is Innolux (TPE:3481) A Risky Investment?

Recent updates

Innolux Corporation to Report Q1, 2024 Results on Apr 19, 2024

Health Check: How Prudently Does Innolux (TWSE:3481) Use Debt?

Consensus EPS estimates fall by 27%

Consensus estimates of losses per share improve by 49%

High number of new directors

Analysts Have Lowered Expectations For Innolux Corporation (TWSE:3481) After Its Latest Results

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

Innolux Corporation, Annual General Meeting, May 31, 2024

Price target increased by 7.0% to NT$16.71

Price target increased by 7.0% to NT$16.71

Price target decreased by 7.5% to NT$14.46

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 9.7% to NT$16.94

Price target increased by 7.9% to NT$18.03

Upcoming dividend of NT$0.50 per share at 6.7% yield

Price target increased by 7.1% to NT$17.63

Consensus estimates of losses per share improve by 13%

Consensus estimates of losses per share improve by 13%

Price target increased by 7.5% to NT$16.41

Price target increased by 12% to NT$16.01

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus estimates of losses per share improve by 12%

Innolux Corporation, Annual General Meeting, May 31, 2023

Price target increased by 7.6% to NT$12.73

Price target increased to NT$12.00

Price target increased to NT$12.11

Consensus EPS estimates fall by 26%

Investor sentiment improved over the past week

Price target increased to NT$11.28

Price target increased to NT$11.18

Consensus forecasts updated

Upcoming dividend of NT$0.95 per share

Price target decreased to NT$10.11

Second quarter 2022 earnings: EPS misses analyst expectations

Consensus forecasts updated

Price target decreased to NT$10.97

Consensus EPS estimates fall by 97%

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$1.05 per share

Innolux Corporation Announces Committee Changes

Price target decreased to NT$12.68

Consensus EPS estimates fall by 15%

Price target decreased to NT$14.16

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 28%

Innolux Corporation to Showcase Metaverse Black Tech At SID Display Week 2022

Price target decreased to NT$15.72

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Innolux Corporation, Annual General Meeting, Jun 24, 2022

Third quarter 2021 earnings released: EPS NT$1.77 (vs NT$0.16 in 3Q 2020)

Price target decreased to NT$18.97

Investor sentiment deteriorated over the past week

Price target decreased to NT$24.71

Price target decreased to NT$24.39

Consensus EPS estimates increase to NT$7.13

Upcoming dividend of NT$0.40 per share

Price target decreased to NT$28.11

Investor sentiment improved over the past week

Consensus EPS estimates increase to NT$6.06

First quarter 2021 earnings released: EPS NT$1.15 (vs NT$0.55 loss in 1Q 2020)

Consensus EPS estimates increase to NT$5.55

Price target increased to NT$23.88

Estimating The Intrinsic Value Of Innolux Corporation (TPE:3481)

Price target increased to NT$20.88

Here's Why Innolux (TPE:3481) Can Manage Its Debt Responsibly

Nanjing Huadong Electronics Information & Technology Co., Ltd. (SZSE:000727) agreed to acquire additional 2.57% stake in TPV Technology Limited from Innolux Corporation (TSEC:3481) for approximately CNY 400 million.

Is Now The Time To Look At Buying Innolux Corporation (TPE:3481)?

Full year 2020 earnings released: EPS NT$0.17 (vs NT$1.77 loss in FY 2019)

Revenue and earnings beat expectations

Price target raised to NT$17.94